| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/12/2001 | WO2000061755A3 Secreted human proteins |
| 04/12/2001 | WO2000056304A3 Anti-inflammatory uses of manzamines |
| 04/12/2001 | WO2000053182A3 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis |
| 04/12/2001 | WO2000048582A3 Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence |
| 04/12/2001 | DE19948428A1 Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel New LTB¶4¶ antagonist, process for its preparation and its use as a medicament |
| 04/12/2001 | CA2699662A1 Rhodamine derivatives for photodynamic diagnosis, prevention and treatment of immunologic disorders |
| 04/12/2001 | CA2645397A1 Formulation for menopausal women |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2388785A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2388227A1 A human gene over-expressing animal and test methods using the animal |
| 04/12/2001 | CA2387703A1 Method for calming human beings using personal care compositions |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386419A1 Method for preparing steroids modified by yeast fermentation |
| 04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | CA2386377A1 Cell targeting compositions and methods of using the same |
| 04/12/2001 | CA2386252A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 04/12/2001 | CA2386246A1 Altering gene expression with ssdna produced in vivo |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386236A1 Human inwardly rectifying potassium channel subunit |
| 04/12/2001 | CA2386228A1 Stabilized liquid pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) polypeptides |
| 04/12/2001 | CA2386157A1 Amide compounds |
| 04/12/2001 | CA2386147A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/12/2001 | CA2385930A1 Synergistic combinations of an nk1 receptor antagonist and a gaba structural analog |
| 04/12/2001 | CA2385864A1 Compositions and methods relating to the inhibition of casomorphin and gluteomorphin |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385551A1 Metal-binding compounds and uses therefor |
| 04/12/2001 | CA2385528A1 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | CA2385251A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | CA2385244A1 Novel nicotinonitrile compounds |
| 04/12/2001 | CA2385210A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | CA2385045A1 Ifn-alpha homologues |
| 04/12/2001 | CA2382691A1 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/12/2001 | CA2351075A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/11/2001 | EP1090991A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090925A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090917A1 Quinolin-4-yl derivatives and their use as NMDA-receptor subtype blockers |
| 04/11/2001 | EP1090915A1 Polymorphic B form of 3-(cyclopropylmethoxy)-4-[-4-(methylsulfonyl)phenyl]- 5,5-dimethyl-5H-furan-2-one |
| 04/11/2001 | EP1090638A1 Use of (R)-zacopride or a salt thereof for the manufacture of a medicament for the treatment of sleep apnea |
| 04/11/2001 | EP1090637A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/11/2001 | EP1090122A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 04/11/2001 | EP1090118A2 Human signal peptide-containing proteins |
| 04/11/2001 | EP1090105A1 Ependymal neural stem cells and method for their isolation |
| 04/11/2001 | EP1090030A1 Compounds of unstable dipeptidyl peptidase iv inhibitors |
| 04/11/2001 | EP1090019A1 Adenosine derivatives |
| 04/11/2001 | EP1090004A1 A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom |
| 04/11/2001 | EP1089997A1 4,5,6 and 7-indole and indoline derivatives, their preparation and use |
| 04/11/2001 | EP1089996A1 Paroxetine methanesulfonate |
| 04/11/2001 | EP1089995A1 Paroxetine ascorbate |
| 04/11/2001 | EP1089994A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 04/11/2001 | EP1089993A1 5-ht 1f? agonists |
| 04/11/2001 | EP1089990A1 1-(benzothiazol-2-yl)-4-(1-phenylmethyl)piperazines: dopamine receptor subtype specific ligands |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089981A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis. |
| 04/11/2001 | EP1089980A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 04/11/2001 | EP1089977A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 04/11/2001 | EP1089962A1 2-fluoro-2-alkyl alkanoamides with anticonvulsant activity |
| 04/11/2001 | EP1089752A1 Alpha-keto oxadiazoles as serine protease inhibitors |
| 04/11/2001 | EP1089746A1 Extracts of hypericum perforatum and formulations containing them |
| 04/11/2001 | EP1089744A2 Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-l-carnitine and hypericin |
| 04/11/2001 | EP1089735A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 04/11/2001 | EP1089733A2 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| 04/11/2001 | EP1089725A1 The use of valproic acid analog for the treatment and prevention of migraine and affective illness |
| 04/11/2001 | EP1089724A1 Therapeutic compositions and methods of use |
| 04/11/2001 | EP1089723A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 04/11/2001 | EP0873317B1 Pyrimidin derivatives |
| 04/11/2001 | EP0854709B1 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 04/11/2001 | EP0775113B1 N-substituted azabicycloheptane derivatives useful as neuroleptics |
| 04/11/2001 | CN1291194A Substituted 1,2,4-triazolo [3,4-a] pyridazine |
| 04/11/2001 | CN1291184A Cycloalkene derivatives, process for producing the same and use |
| 04/11/2001 | CN1291102A Pharmaceutical preparation for selectively supplementing oestrogen deficiency in the central nervous system |
| 04/11/2001 | CN1291099A Heterocyclic compounds, their, production and use |
| 04/11/2001 | CN1291097A Morphine sulphate microgranules, method for making same and pharmaceutical preparations |
| 04/11/2001 | CN1291094A Bicyclic pyrrole derivatives as MCP-1 inhibitor |
| 04/11/2001 | CN1291093A Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 04/11/2001 | CN1291092A pharmaceutical Combinations containing tramadol |
| 04/11/2001 | CN1290700A Phenyl piperazine derivatives |
| 04/11/2001 | CN1290698A Quinoline-4-base deviative I |
| 04/11/2001 | CN1290539A Chinese medicine suppository for carsickness |
| 04/11/2001 | CN1290531A Method for preparing Chinese medicine for curing epilepsy |
| 04/11/2001 | CN1290528A Chinese medicine for curing psychosis and its preparing method |
| 04/11/2001 | CN1290525A Freeze dried zhalaipulong instant oral composition |
| 04/11/2001 | CN1064363C Morphine and diamorphine salts of anionic non-narcotic analgesics of substituted carboxylic acid type |
| 04/11/2001 | CN1064361C Xanthine compounds having terminally aminated alkynol side chains |
| 04/11/2001 | CN1064358C Benyl piperidine derivatives |
| 04/11/2001 | CN1064356C New piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds process for preparation thereof, and pharmaceutical composition containing them |
| 04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
| 04/11/2001 | CN1064351C Substituted indanylidineacetylguanidine, process for their paraparation, their use as medicaments ofdiagonstic and medicaments containing them |
| 04/11/2001 | CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives |
| 04/11/2001 | CN1064349C Novel tricyclic amide, its preparing method and medicinal composition |
| 04/11/2001 | CN1064243C Method for preparing traditional Chinese drug for curing car sick |
| 04/11/2001 | CN1064242C Snake poison substitute medicine for give-up drug-taking and pain-killing, and curing senile dementia |
| 04/11/2001 | CN1064235C Pharmaceutical application of glucoside A and B of auricledleaf swallowoft |
| 04/10/2001 | US6214991 3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-n-acetic acid, ethyl ester for example; treating complications of diabetes mellitus, such as cataracts, retinopathy, nephropathy, and neuropathy |
| 04/10/2001 | US6214884 Composition comprising ketanserin and L-carnitine or an alkanoyl L-carnitine for the treatment of CRPS |
| 04/10/2001 | US6214878 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/10/2001 | US6214870 Antiarthritic agents; anticancer agents |